239
Participants
Start Date
October 16, 2019
Primary Completion Date
October 31, 2023
Study Completion Date
October 31, 2023
Infliximab
No standard dosing regimen will be used and the dose will be determined by the treating physician
Adalimumab
No standard dosing regimen will be used and the dose will be determined by the treating physician
Nationwide Children's Hospital, Columbus
Cincinnati Children's Hospital, Cincinnati
Medical College of Wisconsin, Milwaukee
Connecticut Children's Medical Center, Hartford
The Leona M. and Harry B. Helmsley Charitable Trust
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER